Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage
- PMID: 29438097
- DOI: 10.1136/thoraxjnl-2017-211135
Rapamycin for lymphangioleiomyomatosis: optimal timing and optimal dosage
Keywords: lymphangioleiomyomatosis; rapamycin; sirolimus.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Lung function response and side effects to rapamycin for lymphangioleiomyomatosis: a prospective national cohort study.Thorax. 2018 Apr;73(4):369-375. doi: 10.1136/thoraxjnl-2017-210872. Epub 2017 Oct 9. Thorax. 2018. PMID: 28993539
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources